DAFNA Capital Management LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 134 filers reported holding KARUNA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,940,296
-2.2%
52,873
+25.4%
2.78%
+11.2%
Q2 2023$9,145,215
-35.9%
42,173
-46.3%
2.50%
-41.6%
Q1 2023$14,272,000
+0.8%
78,573
+9.1%
4.28%
+7.4%
Q4 2022$14,153,306
+117.8%
72,027
+149.3%
3.99%
+128.2%
Q3 2022$6,497,000
-17.2%
28,886
-53.4%
1.75%
-18.4%
Q2 2022$7,850,000
-24.5%
62,053
-24.4%
2.14%
-21.1%
Q1 2022$10,403,000
+9.7%
82,053
+13.3%
2.71%
+13.6%
Q4 2021$9,487,000
+4.0%
72,423
-2.9%
2.39%
-1.4%
Q3 2021$9,124,000
+51.0%
74,585
+40.7%
2.42%
+91.7%
Q2 2021$6,041,000
+4.7%
53,000
+10.4%
1.26%
-7.7%
Q1 2021$5,771,000
+240.9%
48,000
+188.0%
1.37%
+171.6%
Q4 2020$1,693,000
+137.1%
16,668
+80.6%
0.50%
+117.2%
Q3 2020$714,000
-30.6%
9,2310.0%0.23%
-21.9%
Q2 2020$1,029,000
+129.2%
9,231
+48.1%
0.30%
+58.8%
Q1 2020$449,000
+145.4%
6,231
-44.3%
0.19%
+171.0%
Q3 2019$183,000
-8.5%
11,192
+11.9%
0.07%
-8.0%
Q2 2019$200,00010,0000.08%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders